Liminal BioSciences Inc. Gains 40%

Wed, Jul 12, 2023 at 07:38 PM
Liminal BioSciences Inc. Gains 40%

Liminal BioSciences Inc. (LMNL:NASDAQ) jumped higher at $8.33, representing a gain of 40%. On Wed, Jul 12, 2023, LMNL:NASDAQ hit a New 2-Week High of $8.33. The stock appeared on our News Catalysts scanner on Wed, Jul 12, 2023 at 08:05 AM in the 'AGREEMENT' category. From Wed, Jun 28, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days

About Liminal BioSciences Inc. (LMNL:NASDAQ)

Liminal Biosciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation, and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.